Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03604133 · ClinicalTrials.gov registry record
Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
A clinical trial of Arrhythmia, sponsored by QuesGen Systems.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT03604133: Recruiting study of Arrhythmia, sponsored by QuesGen Systems.
NCT03604133 is a study of Arrhythmia that is actively recruiting participants, run by QuesGen Systems. The registered enrollment target is 500 participants, below the 1,857-participant average among 16 other Arrhythmia trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03604133, a study of Arrhythmia, is actively recruiting participants, sponsored by QuesGen Systems.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.
Primary Outcome
Patient undergoes surgery for ICD device implantation
Conditions Studied
Study Locations (1)
Utah
- Cardio Surgical Partners, LLC - Lehi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-08-24 |
| Est. Completion | 2028-08-24 |
What NCT03604133 shows while recruiting
NCT03604133 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,857-participant average among 16 other Arrhythmia trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Arrhythmia appearing as the primary indexed condition, and to 0 interventions.
NCT03604133 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT03604133 about?
NCT03604133 is a clinical study titled "Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry". The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data c...
What is the current status of trial NCT03604133?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2017-08-24. Estimated completion is 2028-08-24.
What conditions does trial NCT03604133 study?
This clinical trial studies the following conditions: Arrhythmia.
Who is sponsoring clinical trial NCT03604133?
This trial is sponsored by QuesGen Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03604133 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arrhythmia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03604133's enrollment target sits among peer trials
500 8th of 16 higher than 9 of 16 other Arrhythmia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Arrhythmia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RECRUITING
-
Genetics of Cardiovascular and Neuromuscular Disease
RECRUITING
-
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
RECRUITING
-
Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation
RECRUITING · NA
-
Aveir AR Coverage With Evidence Development (CED) Study
RECRUITING
-
Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI